Who is sponsoring NCT07585877?

NCT07585877 is sponsored by Zhongda Hospital.

What drugs are being tested in NCT07585877?

Interventions in NCT07585877: Branched-Chain Amino Acids (BCAA) Supplementation.

What condition does NCT07585877 study?

NCT07585877 studies Myopia Progressing, Myopia.

Is NCT07585877 still recruiting?

NCT07585877 is currently active, enrolled.

Last reviewed 2026-06-10 · How we verify

NCT07585877

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Branched-Chain Amino Acid Supplementation on Myopia Progression

Active, enrolled NA

What this trial tests

NA trial testing Branched-Chain Amino Acids (BCAA) Supplementation in Myopia Progressing in 108 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

5 January 2026

30 January 2027

Quick facts

Lead sponsor	Zhongda Hospital
Phase	NA
Status	Active, enrolled
Enrollment	108
Start date	5 January 2026
Estimated completion	30 January 2027

Drugs / interventions tested

Branched-Chain Amino Acids (BCAA) Supplementation

Conditions studied

Myopia Progressing — all drugs for Myopia Progressing →
Myopia — all drugs for Myopia →

Sponsor

Zhongda Hospital

Who can join

Eligibility, any sex, with Myopia Progressing or Myopia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Myopia Progressing

Currently open trials in the same condition.

NCT07298824 — Clinical Efficacy and Mechanism Exploration of MR-61 in Delaying the Progression of Myopia · Phase 2 · recruiting
NCT06927414 — Light Diffraction Glasses in Preventing and Controlling Myopia in Adolescents · NA · active not recruiting

Other Zhongda Hospital trials

Trials by the same sponsor.

NCT07516704 — Safety and Efficacy of Docetaxel, Darolutamide, and Homoharringtonine Combined With Androgen Deprivation Therapy in Neoa · EARLY_PHASE1 · not yet recruiting
NCT07504731 — Trunk Inclination, Positive End-expiratory Pressure, and Lung Recruitability · recruiting
NCT07351669 — A Multicenter Prospective Study on the Performance of Spectral CT for Evaluating Treatment Response After TACE in Hepato · recruiting
NCT07311915 — Propranolol Combined With Novel Endocrine Therapy and Androgen Deprivation Therapy (ADT) for Neoadjuvant Treatment in Hi · NA · not yet recruiting
NCT07337980 — A Study on the Safety and Effectiveness of Endoscopic Intracavitary Submucosal Dissection for Gastric Extracavitary-Type · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07585877 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zhongda Hospital
Last refreshed: recently

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07585877.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing